While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

CSL Seqirus and GSK, under contract with HHS, are testing vaccines targeting a strain of avian influenza closely related to the one circulating in dairy cows. Each company is running trials in ...

Stefan Merlo, Vice President of Commercial Development at Seqirus, shares thoughts on the recent innovations in influenza vaccine technology.